MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
BIOA — BioAge Labs, Inc. Common Stock
NasdaqBioAge Labs, Inc. Common Stock
$6.61
-0.20(-2.94%)
- O
- 6.92
- H
- 6.92
- L
- 6.47
- V
- 869.62K
⏱️ End-of-day dataAs of Oct 2, 2026
BIOA — Latest News & Headlines
8 StoriesBioAge Labs (Nasdaq:BIOA) - Stock Analysis - Simply Wall Street
BioAge Labs (Nasdaq:BIOA) - Stock Analysis Simply Wall Street
BIOA, GLUE Stocks Clock Worst Day In Years— What’s The NVO Connection? - Stocktwits
BIOA, GLUE Stocks Clock Worst Day In Years— What’s The NVO Connection? Stocktwits
Understanding the Setup: (BIOA) and Scalable Risk - Stock Traders Daily
Understanding the Setup: (BIOA) and Scalable Risk Stock Traders Daily
BioArctic staff can earn free shares if returns hit 30% - stocktitan.net
BioArctic staff can earn free shares if returns hit 30% stocktitan.net
At Home Leqembi Approval Could Be A Game Changer For BioArctic Stock (OM:BIOA B) - Simply Wall Street
At Home Leqembi Approval Could Be A Game Changer For BioArctic Stock (OM:BIOA B) Simply Wall Street
Is BioArctic (OM:BIOA B) Fairly Valued Following Leqembi's First Private Clinic Use In Sweden? - Simply Wall Street
Is BioArctic (OM:BIOA B) Fairly Valued Following Leqembi's First Private Clinic Use In Sweden? Simply Wall Street
European Growth Stocks Insiders Are Betting On - Simply Wall Street
European Growth Stocks Insiders Are Betting On Simply Wall Street
BioAge Labs initiates Phase 2 trial for BGE-102 - TipRanks
BioAge Labs initiates Phase 2 trial for BGE-102 TipRanks